These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20402282)

  • 1. Pricing strategies for combination pediatric vaccines and their impact on revenue: Pediarix or Pentacel?
    Robbins MJ; Jacobson SH; Sewell EC
    Health Care Manag Sci; 2010 Mar; 13(1):54-64. PubMed ID: 20402282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between pediatric combination vaccines and market effects.
    Behzad B; Jacobson SH; Jokela JA; Sewell EC
    Am J Public Health; 2014 Jun; 104(6):998-1004. PubMed ID: 24825198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel).
    Johns TL; Hutter GE
    Ann Pharmacother; 2010 Mar; 44(3):515-23. PubMed ID: 20197476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pricing strategies for combination pediatric vaccines based on the lowest overall cost formulary.
    Behzad B; Jacobson SH; Sewell EC
    Expert Rev Vaccines; 2012 Oct; 11(10):1189-97. PubMed ID: 23176652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a new combined vaccine in pediatric practices.
    Freed GL; Cowan AE; Clark SJ; Santoli J; Bradley J
    Pediatrics; 2006 Aug; 118(2):e251-7. PubMed ID: 16831895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing the challenges to immunization practice with an economic algorithm for vaccine selection.
    Weniger BG; Chen RT; Jacobson SH; Sewell EC; Deuson R; Livengood JR; Orenstein WA
    Vaccine; 1998 Nov; 16(19):1885-97. PubMed ID: 9795397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial.
    Guerra FA; Blatter MM; Greenberg DP; Pichichero M; Noriega FR;
    Pediatrics; 2009 Jan; 123(1):301-12. PubMed ID: 19117896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, and haemophilus B conjugate vaccine and guidance for use in infants and children.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(39):1079-80. PubMed ID: 18830213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interchangeability of two diphtheria and tetanus toxoids, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate vaccines as a fourth dose in 15-20-month-old toddlers.
    Halperin SA; Tapiero B; Law B; Diaz-Mitoma F; Duval B; Langley JM; Elrick DB; Jacquet JM
    Vaccine; 2006 May; 24(18):4017-23. PubMed ID: 16516357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccine.
    Halperin SA; Tapiéro B; Dionne M; Meekison W; Diaz-Mitoma F; Zickler P; Rubin E; Embree J; Bhuyan P; Lee A; Li M; Tomovici A
    Pediatr Infect Dis J; 2014 Jan; 33(1):73-80. PubMed ID: 24346596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DTaP-IPV/Hib vaccine (Pentacel).
    Dhillon S; Keam SJ
    Paediatr Drugs; 2008; 10(6):405-16. PubMed ID: 18998751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public health impact of Infanrix hexa™ (DTPa-HBV-IPV/Hib) reimbursement: A study programme in France. Part 2: Evolution of the acceptability of infants' vaccination against hepatitis B in general and pediatric practices - the PRALINE study.
    Vié le Sage F; Gaudelus J; Lert F; Dufour V; Texier N; Pouriel M; Schück S; Tehard B; Bréart G
    Rev Epidemiol Sante Publique; 2016 Jun; 64(3):185-94. PubMed ID: 27238163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public health impact of Infanrix hexa (DTPa-HBV-IPV/Hib) reimbursement: A study programme in France. Part 1: Evolution of hepatitis B vaccine coverage rates in infants aged less than 27 months, in the general population - the PopCorn study.
    Gaudelus J; Vié le Sage F; Dufour V; Lert F; Texier N; Pouriel M; Tehard B; Bréart G
    Rev Epidemiol Sante Publique; 2016 Feb; 64(1):23-32. PubMed ID: 26748972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b combination vaccination.
    Pichichero ME; Blatter MM; Reisinger KS; Harrison CJ; Johnson CE; Steinhoff MC; Senders SD; Rothstein EP; Willems P; Howe BJ
    Pediatr Infect Dis J; 2002 Sep; 21(9):854-9. PubMed ID: 12352809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA licensure of diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant), and poliovirus vaccine combined, (PEDIARIX) for use in infants.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Mar; 52(10):203-4. PubMed ID: 12653460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated costs attributable to events of "out-of-temperature" in the stockpiling of hexavalent vaccines occurring in Italy.
    Silvestri R; Marchetti F
    Ann Ig; 2015; 27(5):705-10. PubMed ID: 26661911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Reverse engineering" a formulary selection algorithm to determine the economic value of pentavalent and hexavalent combination vaccines.
    Sewell EC; Jacobson SH; Weniger BG
    Pediatr Infect Dis J; 2001 Nov; 20(11 Suppl):S45-56. PubMed ID: 11704724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the immune response to antigens contained in infant vaccines routinely used in the United States.
    Marshall GS; Marchant CD; Blatter M; Friedland LR; Aris E; Miller JM
    Hum Vaccin; 2011 Feb; 7(2):258-64. PubMed ID: 21307655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine and Guidance for Use as a Booster Dose.
    Liang J; Wallace G; Mootrey G
    MMWR Morb Mortal Wkly Rep; 2015 Sep; 64(34):948-9. PubMed ID: 26334944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine.
    Tejedor JC; Moro M; Ruiz-Contreras J; Castro J; Gómez-Campderá JA; Navarro ML; Merino JM; Martín-Ancel A; Roca J; García-del-Río M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Boceta R; García-Corbeira P; Jacquet JM; Collard A; Schuerman L;
    Pediatr Infect Dis J; 2006 Aug; 25(8):713-20. PubMed ID: 16874171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.